Lung research hints at fresh therapy

Key points
- Evidence of blood vessel damage in the lungs of smokers with early lung disease could lead researchers towards new drugs.
- Patients with chronic obstructive pulmonary disease (COPD) have often suffered so much damage to their lungs by the time they are diagnosed that there is little that can be done to help them.
- The illness, a combination of emphysema and chronic bronchitis, is often caused by long-term smoking.
- The only therapy is giving oxygen, which delivers some benefits but cannot prevent eventual deterioration and death from the illness.
Evidence of blood vessel damage in the lungs of smokers with early lung disease could lead researchers towards new drugs.
Patients with chronic obstructive pulmonary disease (COPD) have often suffered so much damage to their lungs by the time they are diagnosed that there is little that can be done to help them.
The illness, a combination of emphysema and chronic bronchitis, is often caused by long-term smoking.
" The tragedy of COPD is that by the time symptoms are bad enough to make the patient come to see us, the damage has already been done "
Professor Alyn Morice, University of Hull
The only therapy is giving oxygen, which delivers some benefits but cannot prevent eventual deterioration and death from the illness.
It is the most common cause of respiratory-related death in the UK - and 56% of all working days lost among men are due to it, costing the economy many billions of pounds each year.
There is debate among doctors about whether to try to develop treatments for the lungs of the patients - or the blood vessels supplying the lungs.
The latest research, published in the European Respiratory Journal, could help push research towards the blood vessels.
A team from the University of Barcelona in Spain looked at lung samples from smokers with "moderate" COPD.
They found telltale signs of the damage to pulmonary arteries - the blood vessels which supply the lungs.
This "remodelling" of the arteries suggests that changes caused by cigarette smoking may occur at an early stage in COPD .
Potential drugs to control this remodelling process have been tested in animals, and some experts are convinced that they could be used to at least relieve the symptoms and slow the deterioration of COPD sufferers.
Funding fight
Professor Alyn Morice, a COPD expert from Hull University, has supported this theory for some time - but has been unable to convince pharmaceutical companies to give him funding to test potential drugs.
He said: "These findings mean that we can concentrate on the blood supply to the lungs as a potential target for drug therapies.
"The tragedy of COPD is that by the time symptoms are bad enough to make the patient come to see us, the damage has already been done.
"Every 40-year-old should have their lung function checked by their GP, and if problems show up, they could be advised to stop smoking before substantial damage occurs."
[BBC News Online]
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsResearchers Profile Teens Who Seek Help to Quit Smoking
Teen smokers who volunteer for programs to help them quit are more hooked on tobacco than other teens who smoke, new West Virginia University research has found. The teens believe quitting is a good idea, but they…
20 September 2008
NewsResearch reveals molecular fingerprint of cocaine addiction
The first large-scale analysis of proteins in the brains of monkeys addicted to cocaine reveals new information on how long-term cocaine use changes the amount and activity of various proteins affecting brain function.…
28 May 2008
NewsResearch sheds new light on heroin addiction
Researchers from the Howard Florey Institute in Melbourne have identified a factor that may contribute towards the development of heroin addiction by manipulating the adenosine A2A receptor, which plays a major role in…

